Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

Oxygen Biotherapeutics, Inc. (OXBT)

-NasdaqCM
3.91 Down 0.01(0.26%) Jul 30, 4:00PM EDT
Prev Close:3.92
Open:3.89
Bid:3.05 x 2000
Ask:4.15 x 17500
1y Target Est:10.50
Beta:0.41
Next Earnings Date:N/A
Day's Range:3.76 - 3.96
52wk Range:1.19 - 9.75
Volume:275,700
Avg Vol (3m):487,489
Market Cap:67.07M
P/E (ttm):N/A
EPS (ttm):-3.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OXBT

Comparison

Symbol% ChgMkt Cap
OXBTDown 0.26%67.07M
NVSUp 0.26%214.57B
PFEDown 0.71%186.64B
RHHBYUp 0.75%250.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):133.74
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Apr-15) :-0.50
Quarterly EPS Est (Jul-14) :-0.13
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback